XML 44 R34.htm IDEA: XBRL DOCUMENT v3.8.0.1
SUBSEQUENT EVENTS (Details) - United Therapeutics - Steady Med - Subsequent Events
$ / shares in Units, $ in Millions
Apr. 29, 2018
USD ($)
$ / shares
Subsequent events  
Transaction value | $ $ 216
Contingent consideration | $ $ 75
Acquisition share price $ 4.46
Additional acquisition share price contingent upon commercialization of steadyMed's Trevyent Product 2.63
Maximum exercise price of options to receive consideration 7.09
Right to receive consideration for each outstanding warrant issued pursuant to 2017 subscription agreement 2.33
Right to receive consideration for each outstanding warrant issued pursuant to 2016 subscription agreement $ 2.71